May 29, 2023

MSD Animal Health presents new data highlighting commitment to the health and well-being of swine

MSD Animal Health, a division of Merck & Co., announced on May 24 the presentation of 19 abstracts at the 14th European Symposium of Porcine Health Management (ESPHM), highlighting new research across the company's broad swine portfolio, including its intradermal vaccine, PORCILIS® Lawsonia ID.

ESPHM 2023 will be held in Thessaloniki, Greece, from May 31 to June 2, 2023.

The company will also present data on a new rapid blood progesterone kit by comparing it to a laboratory-based progesterone assay and to the reproductive status of the gilt as measured by postmortem examination of the reproductive tract at an oral presentation on the "Flash Talks" session from the symposium, which would take place on June 1.

"As a company dedicated to the health and well-being of swine and the sustainability of pig farms, MSD Animal Health is pleased to share data across our innovative portfolio of vaccines, health management solutions and value-added services," said Rika Jolie, head of global swine at MSD Animal Health.

"This new research emphasises our commitment to the science for healthier animals and demonstrates how the company’s latest scientific advances, products and services can benefit both the swine and the farmer."

MSD Animal Health's scientific publications will be available on its website after the congress.

- MSD Animal Health